Cytosorbents Crp Stock Retained Earnings
CTSO Stock | USD 1.06 0.01 0.93% |
Cytosorbents Crp fundamentals help investors to digest information that contributes to Cytosorbents Crp's financial success or failures. It also enables traders to predict the movement of Cytosorbents Stock. The fundamental analysis module provides a way to measure Cytosorbents Crp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cytosorbents Crp stock.
Last Reported | Projected for Next Year | ||
Retained Earnings | -254.3 M | -241.5 M | |
Retained Earnings Total Equity | -228.6 M | -217.2 M |
Cytosorbents | Retained Earnings |
Cytosorbents Crp Company Retained Earnings Analysis
Cytosorbents Crp's Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Current Cytosorbents Crp Retained Earnings | (282.51 M) |
Most of Cytosorbents Crp's fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cytosorbents Crp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cytosorbents Retained Earnings Driver Correlations
Understanding the fundamental principles of building solid financial models for Cytosorbents Crp is extremely important. It helps to project a fair market value of Cytosorbents Stock properly, considering its historical fundamentals such as Retained Earnings. Since Cytosorbents Crp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Cytosorbents Crp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Cytosorbents Crp's interrelated accounts and indicators.
Click cells to compare fundamentals
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
Competition |
Based on the latest financial disclosure, Cytosorbents Crp has a Retained Earnings of (282.51 Million). This is 130.33% lower than that of the Health Care Equipment & Supplies sector and 137.75% lower than that of the Health Care industry. The retained earnings for all United States stocks is 103.03% higher than that of the company.
Cytosorbents Retained Earnings Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cytosorbents Crp's direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cytosorbents Crp could also be used in its relative valuation, which is a method of valuing Cytosorbents Crp by comparing valuation metrics of similar companies.Cytosorbents Crp is currently under evaluation in retained earnings category among its peers.
Cytosorbents Crp Current Valuation Drivers
We derive many important indicators used in calculating different scores of Cytosorbents Crp from analyzing Cytosorbents Crp's financial statements. These drivers represent accounts that assess Cytosorbents Crp's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Cytosorbents Crp's important valuation drivers and their relationship over time.
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Market Cap | 309.4M | 181.7M | 67.5M | 49.6M | 44.6M | 42.4M | |
Enterprise Value | 239.0M | 143.4M | 63.6M | 53.8M | 48.4M | 93.7M |
Cytosorbents Fundamentals
Return On Equity | -1.18 | ||||
Return On Asset | -0.28 | ||||
Profit Margin | (0.49) % | ||||
Operating Margin | (0.46) % | ||||
Current Valuation | 86.32 M | ||||
Shares Outstanding | 60.93 M | ||||
Shares Owned By Insiders | 9.36 % | ||||
Shares Owned By Institutions | 30.82 % | ||||
Number Of Shares Shorted | 1.95 M | ||||
Price To Earning | (16.30) X | ||||
Price To Book | 5.02 X | ||||
Price To Sales | 1.71 X | ||||
Revenue | 36.35 M | ||||
Gross Profit | 23.67 M | ||||
EBITDA | (29.18 M) | ||||
Net Income | (28.51 M) | ||||
Cash And Equivalents | 30.16 M | ||||
Cash Per Share | 0.69 X | ||||
Total Debt | 18.31 M | ||||
Debt To Equity | 0.28 % | ||||
Current Ratio | 3.95 X | ||||
Book Value Per Share | 0.24 X | ||||
Cash Flow From Operations | (21.66 M) | ||||
Short Ratio | 15.13 X | ||||
Earnings Per Share | (0.36) X | ||||
Target Price | 5.0 | ||||
Number Of Employees | 186 | ||||
Beta | 0.62 | ||||
Market Capitalization | 64.59 M | ||||
Total Asset | 53.26 M | ||||
Retained Earnings | (282.51 M) | ||||
Working Capital | 11.16 M | ||||
Current Asset | 9.05 M | ||||
Current Liabilities | 5 M | ||||
Net Asset | 53.26 M |
About Cytosorbents Crp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cytosorbents Crp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cytosorbents Crp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cytosorbents Crp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
When determining whether Cytosorbents Crp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cytosorbents Crp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cytosorbents Crp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cytosorbents Crp Stock: Check out Cytosorbents Crp Piotroski F Score and Cytosorbents Crp Altman Z Score analysis. To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytosorbents Crp. If investors know Cytosorbents will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytosorbents Crp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.36) | Revenue Per Share | Quarterly Revenue Growth 0.066 | Return On Assets | Return On Equity |
The market value of Cytosorbents Crp is measured differently than its book value, which is the value of Cytosorbents that is recorded on the company's balance sheet. Investors also form their own opinion of Cytosorbents Crp's value that differs from its market value or its book value, called intrinsic value, which is Cytosorbents Crp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytosorbents Crp's market value can be influenced by many factors that don't directly affect Cytosorbents Crp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytosorbents Crp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytosorbents Crp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytosorbents Crp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.